+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Anti-infectives Market by Product Type, Route of Administration, Animal Type, Distribution Channel, Application - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532791
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Veterinary Anti-infectives Market is projected to reach USD 10.45 Billion in 2026. It is expected to continue growing at a CAGR of 14.03%, reaching USD 23.07 Billion by 2032.

Veterinary anti-infectives are central to animal health, food security, and zoonotic disease control, spanning antibacterial, antifungal, antiviral, and related therapeutic classes used in livestock, poultry, aquaculture, and companion animals. Demand is supported by growth in animal protein consumption, expanding pet ownership, intensifying veterinary care, and the need to reduce disease-related productivity losses across farms, aquaculture systems, and veterinary clinics.

The veterinary anti-infectives market is increasingly shaped by antimicrobial resistance stewardship, prescription-only frameworks, residue monitoring, and evidence-based treatment protocols. Industry leaders are competing on differentiated formulations, targeted delivery, diagnostic-linked prescribing, pharmacovigilance, and compliance with guidance from regulators and public health bodies such as the FDA, EMA, WHO, WOAH, FAO, EFSA, and national veterinary authorities.

Transformative Shifts in the Veterinary Anti-infectives Landscape

The veterinary anti-infectives landscape is shifting from volume-driven treatment toward responsible, precision-based use. Regulatory actions such as the U.S. Veterinary Feed Directive, restrictions on medically important antimicrobials for production purposes, the European Union ban on routine antibiotic use for prophylaxis, and global antimicrobial resistance surveillance programs are accelerating the transition to prescription oversight, veterinary stewardship, and documented treatment justification.

At the same time, producers and veterinarians are adopting rapid diagnostics, improved biosecurity, vaccination, microbiome-supportive strategies, farm management software, and herd health analytics to reduce unnecessary antimicrobial exposure. This is changing product portfolios, favoring narrow-spectrum therapies, shorter withdrawal periods, improved palatability, injectable convenience, species-specific dosing, and formulations aligned with animal welfare, residue compliance, and food-chain safety expectations.

Cumulative Impact of Artificial Intelligence on Veterinary Anti-infectives

Artificial intelligence is creating cumulative value across veterinary anti-infectives by improving disease detection, susceptibility prediction, pharmacovigilance, and treatment decision support. AI-enabled imaging, sensor data, electronic medical records, diagnostic platforms, and farm management systems can identify early signs of infection, helping veterinarians intervene faster while supporting more selective antimicrobial use.

In research and commercial operations, AI accelerates compound screening, resistance pattern analysis, adverse event detection, literature surveillance, inventory planning, and prescribing workflow optimization. Its strongest near-term impact is in antimicrobial stewardship, where algorithm-assisted diagnostics, outbreak risk scoring, and treatment pathway support can reduce empirical prescribing, strengthen compliance documentation, and improve outcomes for livestock, aquaculture, and companion animals.

Key Regional Insights Across Major Veterinary Anti-infectives Markets

Asia-Pacific remains a high-priority region for veterinary anti-infectives because of large livestock populations, aquaculture intensity, rising companion animal care, and expanding veterinary infrastructure across China, India, Japan, South Korea, Australia, and Southeast Asia. The region’s animal health priorities are shaped by poultry and swine production, dairy development, export-oriented aquaculture, and growing enforcement of residue and antimicrobial use requirements. North America is defined by mature veterinary channels, strong companion animal spending, FDA and Canadian regulatory oversight, transparent antimicrobial sales reporting, and producer investment in herd health, diagnostics, and biosecurity programs. Latin America is supported by Brazil and Mexico’s significant beef, poultry, swine, and dairy sectors, where export compliance, animal productivity, and disease prevention remain important drivers of responsible anti-infective use.

Europe is strongly influenced by the EU One Health Action Plan, EMA antimicrobial categorization, farm-to-fork food safety rules, residue controls, and documented reductions in sales of veterinary antimicrobials reported through European monitoring programs. These policies continue to reinforce veterinarian-led prescribing, preventive herd health, and restricted use of critically important antimicrobials. The Middle East is expanding veterinary services alongside food security strategies, dairy modernization, poultry investments, and regulated import requirements for animals and animal products. Africa presents long-term need tied to livestock dependency, transboundary animal disease burden, rural veterinary access gaps, and the importance of quality-assured veterinary medicines in supporting food security and smallholder productivity.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is supported by poultry, swine, aquaculture, and dairy expansion, with governments increasingly aligning food safety, residue testing, and animal health programs with responsible antimicrobial use. The group’s diverse production systems create demand for affordable, species-appropriate, and quality-assured veterinary anti-infectives supported by veterinary guidance and improved diagnostic access. The GCC is focused on food security, imported breeding stock, dairy modernization, camel and equine health, and regulated veterinary care, creating demand for high-quality anti-infectives with documented safety, traceability, and residue profiles.

The European Union remains one of the most stewardship-driven environments due to harmonized veterinary medicines regulation, One Health antimicrobial resistance strategies, pharmacovigilance requirements, and restrictions on routine prophylactic antibiotic use. BRICS economies combine large animal populations, expanding domestic pharmaceutical capacity, rising protein demand, and evolving regulatory enforcement, making responsible access and manufacturing quality key strategic themes. G7 markets emphasize innovation, diagnostics, digital veterinary tools, pharmacovigilance, and premium companion animal care, while NATO countries show overlap with advanced regulatory systems, resilient supply-chain planning, biosecurity readiness, and coordinated responses to animal disease threats that can affect food systems and public health.

Key Country Insights in Veterinary Anti-infectives

The United States and Canada benefit from advanced veterinary infrastructure, companion animal expenditure, livestock biosecurity programs, and transparent antimicrobial sales and distribution reporting, while Mexico and Brazil are important livestock-led markets shaped by export compliance, poultry and beef production, dairy modernization, and herd productivity. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong veterinary practice networks with strict stewardship expectations, residue controls, and mature livestock and companion animal care systems, while Russia remains influenced by domestic animal protein production, import substitution dynamics, and the need to maintain access to veterinary medicines across large production geographies.

China and India are pivotal due to scale in livestock, poultry, aquaculture, dairy, and evolving regulatory enforcement around veterinary drug quality, food safety, and antimicrobial resistance. Japan, Australia, and South Korea prioritize quality, traceability, prescription oversight, and responsible use. Australia’s livestock export orientation, strong biosecurity culture, and residue compliance requirements reinforce demand for compliant therapies, while Japan’s high-standard veterinary care and South Korea’s modern companion animal and livestock systems support targeted anti-infective use with strong safety documentation.

Actionable Recommendations for Veterinary Anti-infectives Industry Leaders

Industry leaders should prioritize antimicrobial stewardship as a commercial advantage by investing in rapid diagnostics, susceptibility-linked prescribing tools, veterinarian education, and products designed for targeted therapy. Portfolio strategies should reduce dependence on broad-spectrum usage and emphasize label clarity, species-specific dosing, withdrawal-period compliance, pharmacokinetic evidence, palatability, adherence, and real-world safety documentation.

Manufacturers should strengthen regulatory intelligence across FDA, EMA, EU, and national frameworks while improving supply resilience for active pharmaceutical ingredients, excipients, and finished formulations. Partnerships with veterinary clinics, producer groups, diagnostic developers, academic networks, and digital health platforms can improve treatment outcomes, generate real-world evidence, strengthen pharmacovigilance, and support differentiated positioning across livestock, poultry, aquaculture, and companion animal channels.

Research Methodology for Veterinary Anti-infectives Insights

This executive analysis is based on secondary research from regulatory publications, veterinary medicine guidance, antimicrobial resistance surveillance programs, animal health policy documents, peer-reviewed literature, and public data from organizations including FDA, EMA, WOAH, WHO, FAO, EFSA, and national veterinary authorities. Market interpretation considers animal population trends, animal protein production, aquaculture development, pet care demand, prescribing rules, residue controls, pharmacovigilance requirements, and regional access dynamics.

Qualitative triangulation was applied across policy shifts, product positioning, distribution channels, treatment protocols, and end-user behavior. The methodology emphasizes verified indicators over unsupported estimates, with attention to antimicrobial stewardship, regulatory compliance, innovation pipelines, diagnostic adoption, supply-chain resilience, and commercial adoption patterns across livestock, poultry, aquaculture, and companion animal segments.

Conclusion: Responsible Growth in Veterinary Anti-infectives

The veterinary anti-infectives market is entering a more disciplined era where industry progress depends on balancing animal health needs with antimicrobial resistance mitigation. Demand remains resilient because infections directly affect livestock productivity, companion animal welfare, aquaculture performance, and food-chain continuity, but future value will increasingly come from precision, compliance, diagnostic integration, and evidence-based therapy.

Organizations that align innovation with One Health principles, regional regulation, responsible access, veterinarian-led stewardship, and transparent safety documentation will be best positioned to compete. The strongest opportunities will emerge where targeted anti-infectives, digital decision support, rapid diagnostics, and responsible use strategies converge to protect animal health, public health, and food security together.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Anti-infectives Market, by Product Type
7.1. Antibiotics
7.1.1. Aminoglycosides
7.1.2. Beta Lactams
7.1.3. Fluoroquinolones
7.1.4. Macrolides
7.1.5. Sulfonamides
7.1.6. Tetracyclines
7.2. Antifungals
7.2.1. Azoles
7.2.2. Polyenes
7.3. Antiparasitics
7.3.1. Acaricides
7.3.2. Anthelmintics
7.3.3. Insecticides
8. Veterinary Anti-infectives Market, by Route Of Administration
8.1. Injectable
8.1.1. Intramuscular
8.1.2. Intravenous
8.1.3. Subcutaneous
8.2. Oral
8.2.1. Pellets
8.2.2. Powders
8.2.3. Suspensions
8.2.4. Tablets
8.3. Topical
8.3.1. Creams
8.3.2. Dips
8.3.3. Ointments
8.3.4. Sprays
9. Veterinary Anti-infectives Market, by Animal Type
9.1. Aquaculture
9.1.1. Fish
9.1.2. Shrimp
9.2. Companion Animal
9.2.1. Cats
9.2.2. Dogs
9.3. Livestock
9.3.1. Cattle
9.3.2. Goats
9.3.3. Sheep
9.3.4. Swine
9.4. Poultry
9.4.1. Chicken
9.4.2. Turkey
10. Veterinary Anti-infectives Market, by Distribution Channel
10.1. Online
10.2. Offline
11. Veterinary Anti-infectives Market, by Application
11.1. Prophylactic
11.2. Therapeutic
12. Asia-Pacific Veterinary Anti-infectives Market
13. Europe Veterinary Anti-infectives Market
14. North America Veterinary Anti-infectives Market
15. Latin America Veterinary Anti-infectives Market
16. Africa Veterinary Anti-infectives Market
17. Middle East Veterinary Anti-infectives Market
18. NATO Veterinary Anti-infectives Market
19. G7 Veterinary Anti-infectives Market
20. BRICS Veterinary Anti-infectives Market
21. European Union Veterinary Anti-infectives Market
22. ASEAN Veterinary Anti-infectives Market
23. GCC Veterinary Anti-infectives Market
24. China Veterinary Anti-infectives Market
25. United States Veterinary Anti-infectives Market
26. Japan Veterinary Anti-infectives Market
27. India Veterinary Anti-infectives Market
28. Germany Veterinary Anti-infectives Market
29. United Kingdom Veterinary Anti-infectives Market
30. Australia Veterinary Anti-infectives Market
31. France Veterinary Anti-infectives Market
32. South Korea Veterinary Anti-infectives Market
33. Italy Veterinary Anti-infectives Market
34. Canada Veterinary Anti-infectives Market
35. Russia Veterinary Anti-infectives Market
36. Brazil Veterinary Anti-infectives Market
37. Mexico Veterinary Anti-infectives Market
38. Spain Veterinary Anti-infectives Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. AdvaCare Pharma
40.2. Ashish Life Science Pvt Ltd
40.3. Bimeda Holdings PLC
40.4. Biogenesis Bago
40.5. Boehringer Ingelheim International GmbH
40.6. Ceva Sante Animale
40.7. Dechra Pharmaceuticals PLC
40.8. ECO Animal Health Group Plc
40.9. Elanco Animal Health Incorporated
40.10. Endovac Animal Health
40.11. Hester Biosciences Ltd
40.12. HIPRA SA
40.13. Huvepharma EOOD
40.14. Inovet Group
40.15. Intas Pharmaceuticals Ltd
40.16. Kyoritsu Seiyaku Corporation
40.17. Meiji Holdings Co Ltd
40.18. Merck & Co Inc
40.19. Norbrook Laboratories Ltd
40.20. Ourofino Saude Animal
40.21. Phibro Animal Health Corporation
40.22. SeQuent Scientific Ltd
40.23. Vee Remedies
40.24. Vetoquinol SA
40.25. Vivaldis Health and Foods
40.26. Zoetis Inc
40.27. Zydus Lifesciences Ltd
List of Figures
FIGURE 1. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AZOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AZOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AZOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POLYENES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL POLYENES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL POLYENES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTIPARASITICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTIPARASITICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIPARASITICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ACARICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ACARICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ACARICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTHELMINTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTHELMINTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTHELMINTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INSECTICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INSECTICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INSECTICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PELLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PELLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PELLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SUSPENSIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SUSPENSIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SUSPENSIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL FISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL SHRIMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SHRIMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL SHRIMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COMPANION ANIMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COMPANION ANIMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COMPANION ANIMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CHICKEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CHICKEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL CHICKEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL TURKEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL TURKEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL TURKEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PROPHYLACTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PROPHYLACTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PROPHYLACTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 176. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 178. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 180. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. EUROPE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 216. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 217. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 218. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 219. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 221. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 222. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 223. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 224. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 225. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 226. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 227. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 228. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 229. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 248. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 250. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 251. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 252. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 253. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 254. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 255. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 256. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 257. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 258. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 259. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 260. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 261. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. NATO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 265. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 266. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 267. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 268. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 269. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 270. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 271. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 272. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 273. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 274. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 275. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 276. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 277. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. G7 VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 280. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 282. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 283. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 284. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 285. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 286. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 287. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 288. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 289. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 290. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 291. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 292. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 293. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. BRICS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 311. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 312. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 313. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 314. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 315. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 316. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 317. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 318. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 319. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 320. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 321. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 322. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 323. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 324. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 325. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 326. ASEAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 327. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 328. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 329. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 330. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 331. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 332. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 333. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 334. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 335. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 336. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 337. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 338. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 339. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 340. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 341. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 342. GCC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 343. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 344. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 345. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 346. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 347. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 348. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 349. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 350. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 351. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 352. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 353. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 354. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
TABLE 355. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
TABLE 356. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 357. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 358. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 359. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 360. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 361. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 362. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 363. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASI

Companies Mentioned

The companies featured in this Veterinary Anti-infectives market report include:
  • AdvaCare Pharma
  • Ashish Life Science Pvt Ltd
  • Bimeda Holdings PLC
  • Biogenesis Bago
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Ltd
  • HIPRA SA
  • Huvepharma EOOD
  • Inovet Group
  • Intas Pharmaceuticals Ltd
  • Kyoritsu Seiyaku Corporation
  • Meiji Holdings Co Ltd
  • Merck & Co Inc
  • Norbrook Laboratories Ltd
  • Ourofino Saude Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd
  • Vee Remedies
  • Vetoquinol SA
  • Vivaldis Health and Foods
  • Zoetis Inc
  • Zydus Lifesciences Ltd

Table Information